» Articles » PMID: 20070457

Late Recurrence (10 Years or More) of Malignant Melanoma in South-east Germany (Saxony). A Single-centre Analysis of 1881 Patients with a Follow-up of 10 Years or More

Overview
Date 2010 Jan 15
PMID 20070457
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Late recurrent melanoma (MM) is rare.

Objective: In the present study, we analysed the frequency of late recurrent MM in south-eastern Germany.

Patients And Methods: In our centre, 2314 MM patients were documented (1972-2001). A total of 1881 patients in stage I or II (AJCC) with a follow-up of > or = 10 years were selected and screened for late recurrence (> or = 10 years after diagnosis).

Results: Twenty patients were identified (1.1%), 13 women and 7 men, median age 44 years (age range 30-74 years). Nineteen suffered from cutaneous MM and one had a uveal MM (excluded from further analysis). The primary cutaneous MM occurred on the trunk (6), on the upper limb/shoulder (4), or on the lower limb (9). MM type was superficial spreading (13), nodular (2), acrolentiginous (1), lentigo maligna-type (1) or unclassified (2). Tumour thickness varied from 0.33 mm to 9.5 mm (median 2.0 mm). Ulceration was seen in four, and spontaneous regression in two MM patients. Invasiveness into blood or lymphatic vessels occurred in seven MM patients. The largest period from primary diagnosis to recurrence was 25.1 years with a median of 13.9 years. Metastatic spread was loco-regional (12 patients) or distant (7). Four patients were survivors and three of these had in-transit metastases only. Overall survival was 14.7 +/- 6.6 years. Statistical analysis could not identify factors significantly associated with late recurrence.

Conclusions: Late recurrence is a clinical sign of melanoma dormancy. We conclude that late recurrences argue for a lifelong follow-up of melanoma patients.

Citing Articles

How circulating tumor cluster biology contributes to the metastatic cascade: from invasion to dissemination and dormancy.

Nasr M, Lynch C Cancer Metastasis Rev. 2023; 42(4):1133-1146.

PMID: 37442876 PMC: 10713810. DOI: 10.1007/s10555-023-10124-z.


Risk Stratification and Clinical Characteristics of Patients with Late Recurrence of Melanoma (>10 Years).

Reschke R, Dumann K, Ziemer M J Clin Med. 2022; 11(7).

PMID: 35407631 PMC: 9000041. DOI: 10.3390/jcm11072026.


A 41-Year-Old Woman with a Late Cerebral Metastasis 16 Years After an Initial Diagnosis of Cutaneous Melanoma.

Yu Q, Ma Y, Feng T Am J Case Rep. 2022; 23:e935728.

PMID: 35256582 PMC: 8919240. DOI: 10.12659/AJCR.935728.


The role of RNA processing and regulation in metastatic dormancy.

Parker K, Robinson N, Schiemann W Semin Cancer Biol. 2021; 78:23-34.

PMID: 33775829 PMC: 8464634. DOI: 10.1016/j.semcancer.2021.03.020.


Late Metastatic Melanoma after 25 Years: A Case Report and a Brief Literature Review.

Pescarini E, Spanikova G, Mbaidjol Z, De Antoni E, Vindigni V, Bassetto F Case Rep Surg. 2020; 2020:2938236.

PMID: 33178477 PMC: 7647769. DOI: 10.1155/2020/2938236.